Bezalip SR is a medication that can be prescribed to treatcholesterol disorders. It is indicated for treating abnormally high lipids (hyperlipidemia) and abnormally high triglycerides (hypertriglyceridemia). Bezalip SR works by increasing the number of certain enzymes in the body that help to break down the types of cholesterol called VLDL and triglycerides. It also prevents the body from making more triglyceride molecules. Bezalip SR medication has not been approved for use in the United States by the Food and Drug Administration (FDA). Fact Table Formula C19H20ClNO4 License US FDA Bioavailability 100% Legal status US: Rx-only Chemical Name Bezafibrate Elimination half-life 2 hours Dosage (Strength) 400mg Pregnancy Limited data Brands Bezalip SR Protein binding 95% PubChem CID 39042 MedlinePlus a682711 ChEBI 47612 ATC code C10AB02 DrugBank DB01393 KEGG D01366 Routes of administration Oral